APG Asset Management N.V. Acquires New Shares in Illumina, Inc. (NASDAQ:ILMN)

APG Asset Management N.V. purchased a new stake in shares of Illumina, Inc. (NASDAQ:ILMN) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 9,755 shares of the life sciences company’s stock, valued at approximately $1,259,000.

A number of other large investors have also recently bought and sold shares of the business. Versant Capital Management Inc boosted its stake in shares of Illumina by 153.7% during the 4th quarter. Versant Capital Management Inc now owns 241 shares of the life sciences company’s stock worth $32,000 after acquiring an additional 146 shares in the last quarter. Golden State Wealth Management LLC bought a new stake in Illumina during the fourth quarter worth approximately $32,000. Assetmark Inc. grew its holdings in Illumina by 954.8% during the fourth quarter. Assetmark Inc. now owns 327 shares of the life sciences company’s stock valued at $44,000 after purchasing an additional 296 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich bought a new position in shares of Illumina in the fourth quarter valued at approximately $45,000. Finally, Lee Danner & Bass Inc. acquired a new stake in shares of Illumina in the fourth quarter worth $48,000. 89.42% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on ILMN shares. HSBC lowered shares of Illumina from a “buy” rating to a “hold” rating and set a $100.00 target price on the stock. in a research note on Friday, February 28th. Barclays cut their price objective on Illumina from $100.00 to $77.00 and set an “underweight” rating for the company in a research report on Thursday. Canaccord Genuity Group lowered their target price on Illumina from $135.00 to $115.00 and set a “hold” rating on the stock in a report on Tuesday, March 11th. Royal Bank of Canada cut their price target on Illumina from $128.00 to $112.00 and set an “outperform” rating for the company in a report on Tuesday, April 8th. Finally, Hsbc Global Res lowered shares of Illumina from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 28th. One analyst has rated the stock with a sell rating, ten have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $138.70.

Illumina Price Performance

Shares of Illumina stock opened at $74.78 on Friday. The stock has a market capitalization of $11.85 billion, a price-to-earnings ratio of -9.74, a P/E/G ratio of 1.60 and a beta of 1.38. The firm’s 50-day moving average price is $88.58 and its two-hundred day moving average price is $122.32. The company has a current ratio of 1.77, a quick ratio of 1.42 and a debt-to-equity ratio of 0.63. Illumina, Inc. has a 1-year low of $68.70 and a 1-year high of $156.66.

Illumina (NASDAQ:ILMN) last released its quarterly earnings results on Thursday, February 6th. The life sciences company reported $0.86 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.06). Illumina had a positive return on equity of 13.37% and a negative net margin of 27.95%. On average, equities analysts predict that Illumina, Inc. will post 4.51 earnings per share for the current fiscal year.

Illumina Profile

Illumina, Inc offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest.